$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend YieldSeeking Alpha • 11/20/25
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCERPRNewsWire • 11/19/25
AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIALPRNewsWire • 11/08/25
Amgen (AMGN) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 11/05/25